Icon
+91 94997 68112
Login Register

Butrans - (5,10,20 mcg/Hr; Film, Extended Release)

Buprenorphine Purdue
5,10,20 mcg/Hr; Film, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Yes
****** (*******) ** *** ***** ** **** **** ** **** ******* ’***, ’*** *** ’*** *** ******** ** **** **, **** *** *** ************ *********. ******* ******* **** ***** **** ** **** *** **** ******* *** *** ************ *********. ******* ****** *** ****** ** ** ****** **** ********** *** ******* **** ****** ** **** ** ******* ***** *** ***** ** ********** *** *** *****. ** *** ****, ****** ******** *******. *** ******** ** * ******* ******* *** ***** **** *** ******* ***********. ******* **** ****** ******* **** ********.
Butrans Patent 1 Patent 2 Patent 3
****** ******* ******* *******
******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** ***** **, **** ******* ******** ******** ** *** **, ****
******* ** \ ** *** **, **** ******* ******** ****** **** ********
  1. *** **, **** : ****** (*******) ******** ****** ***** *** **** ** **** ******* ’***, ’*** *** ’*** *** ******** ** **** **, ****.
  2. *** **, **** : ****** ***** * **** ******* ****** (*******) ** ******** ***** ** ********.
  3. *** **, **** : ****** ***** * **** ******* ******* ** ******** ***** ** ******** ** ******* ***** **** ** **** ******* ’***, ’*** *** ’*** *** ******** ** **** **, ****.
  4. *** **, **** : ********** *** ******* **** ******* ***** *** ***** ** ********** *** *** *****.
  5. *** *, **** : ********** *** ******* **** ******* ***** *** ***** ** ********** *** *** *****.

Butrans - (15 mcg/Hr, Film, Extended Release)

Buprenorphine Purdue
15 mcg/Hr, Film, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Indicated for the management of pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Yes
****** (*******) ** *** ***** ** **** **** ** **** ******* ’***, ’*** *** ’*** *** ******** ** **** **, **** *** *** ************ *********. ******* ******* **** ***** **** ** **** *** **** ******* *** *** ************ *********. ******* ****** *** ****** ** ** ****** **** ********** *** ******* **** ****** ** **** ** ******* ***** *** ***** ** ********** *** *** *****. ** *** ****, ****** ******** *******. *** ******** ** * ******* ******* *** ***** **** *** ******* ***********. ******* **** ****** ******* **** ********.
Butrans Patent 1 Patent 2 Patent 3
****** ******* ******* *******
******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** **,**** ******* ******** ******** ** *** **, ****
******* ** \ ** *** **,**** ******* ******** ****** **** ********
  1. *** **, **** : ****** (*******) ******** ****** ***** *** **** ** **** ******* ’***, ’*** *** ’*** *** ******** ** **** **, ****.
  2. *** **, **** : ****** ***** * **** ******* ****** (*******)**** ******* ’***, ’*** *** ’*** *** ******** ** **** **, ****.
  3. *** **, **** : ****** ***** * **** ******* ******* ** ******** ***** ** ******** ** ******* ***** **** ** **** ******* ’***, ’*** *** ’*** *** ******** ** **** **, ****.
  4. *** **, **** : ********** *** ******* **** ******* ***** *** ***** ** ********** *** *** *****.
  5. *** *, **** : ********** *** ******* **** ******* ***** *** ***** ** ********** *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.